MaxCyte (MXCT)
Supplies ExPERT electroporation tools, consumables, licenses, and gene-editing assay services.
$1.24
After hours0.00 (0.00%)
At close$1.24(+1.64%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | ≈ 61.45% | 63.42M shares | |
|---|---|---|---|
| 125 holders · as of Jun 30, 2026 · largest filers plus last quarter's tail | |||
| Insiders | 2.28% | 2.35M shares | |
| 13 holders · as of Jun 22, 2026 | |||
| Other | ≈ 36.27% | 37.43M shares | |
| remainder | |||
103.21M company shares as of Sep 22, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
This quarter's institutional total failed a plausibility check; shown: the largest filers plus last quarter's remainder.
13F, as of Jun 30, 2026
125 holders · 63.42M shares · 28 new positions · 78 increased · 29 reduced · 35 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Capricorn Fund Managers Ltd | 8.20M | 7.95% | 0 | Jul 24, 2026 |
| Vitruvian Partners LLP | 5.04M | 4.89% | 0 | Aug 10, 2026 |
| Vanguard Capital Management LLC | 4.03M | 3.91% | +49.5K | Aug 13, 2026 |
| Morgan Stanley | 3.69M | 3.58% | +5.9K | Aug 13, 2026 |
| Mudita Advisors LLP | 3.37M | 3.27% | 0 | Aug 13, 2026 |
| BlackRock, Inc. | 3.06M | 2.97% | −5.74M | Aug 7, 2026 |
| Brooklands Fund Management Ltd | 2.85M | 2.76% | +658.1K | Aug 11, 2026 |
| BNP Paribas Asset Management Holding S.A. | 2.77M | 2.69% | 0 | Aug 13, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Capricorn Fund Managers Ltd | 7.70% | 8.20M | 13G | Feb 5, 2026 |
| BlackRock, Inc. | 6.60% | 7.00M | 13G | Jan 21, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Mar 17, 2026 | Douglas J. Swirskyofficer: CHIEF FINANCIAL OFFICER | Sale | 10,142 | $0.8150 | 151,669 |
House and Senate disclosures
Not reported.
